Rapid Novor Inc is developing a sensitive and non-invasive blood based liquid biopsy (EasyM) to monitor the minimal residue disease and detect early relapse for Multiple Myeloma. EasyM is sensitive enough to determine MM relapse 6-8 months earlier than traditional tests.
Rapid Novor Inc is developing a sensitive, non-invasive blood based liquid biopsy (EasyM) to monitor minimal residue disease and detect early relapse for Multiple Myeloma. EasyM can determine MM relapse 6-8 months earlier than traditional tests.
Contact this Exhibitor